Five home-testing devices for obstructive sleep apnoea hypopnoea syndrome (OSAHS), a potentially dangerous condition affecting 2.5 million adults in the UK, have been reco
Israeli company Itamar Medical has agreed to acquire Spry Health, aiming to use the US company’s wearable technology to develop a watch-like remote monitor for sleep apnoea, a potentially l
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh